Heart-liver co-management in MASLD: expert perspectives and recommendations from a multidisciplinary cardiometabolic framework.

Multidisciplinary heart-liver co-management improves detection and treatment of MASLD, addressing a critical gap in cardiometabolic care with potential to reduce mortality.

• Why it matters: MASLD is a systemic disorder with significant cardiovascular risks that are often under-recognized, leading to fragmented care and missed opportunities for early intervention.
• What they did: The authors reviewed current diagnostic tools, pharmacotherapies, and clinical practices, emphasizing the need for integrated screening, risk stratification, and multidisciplinary management strategies.
• The result: Implementing coordinated care pathways enables earlier detection and comprehensive treatment of MASLD, potentially improving outcomes for both liver and cardiovascular health.